Endocrinology, Vol 105, 1288-1292, Copyright © 1979 by Endocrine Society

ARTICLES

Impact of continuously administered catechol estrogens on uterine growth and luteinizing hormone secretion

CP Martucci and J Fishman

The biological activity of a series of natural catechol estrogens was examined under conditions of continuous administration. 2- Hydroxyestradiol (2OH-E2), 2-methoxyestradiol (2MeOE2), 4- hydroxyestrone (4OH-E1), 4-methoxyestradiol (4MeOE2), 2-hydroxyestrone (2OH-E1), and 4-methoxyestrone (4MeOE1) were delivered at the rate of 1 microgram/h from osmotic pumps implanted in ovariectomized rats. Uterine growth and plasma LH concentrations were measured 24, 48, and 72 h after implantation. Little or no uterotropic activity was exhibited by the 2-hydroxylated metabolites 2OH-E1 and 2MeOE2 at any interval, while 2OH-E2 exhibited anomalous uterotropic activity, which terminated at 48 h. The 4-hydroxylated compounds 4MeOE2, 4OH-E1, and 4MeOE1 all produced substantial and progressive uterine growth. Tonic LH secretion was suppressed by 2OH-E2, 4OH-E1, and 4MeOE1 in proportion to their uterotropic activity. 2OH-E1 was the only substance which increased plasma LH concentrations. The nuclear receptor occupancy by 2OH-E2 was substantially shorter than that of E2. Binding studies of the test and other related estrogens to the uterine cytosol estradiol receptor showed that their relative binding affinities in many instances did not correlate with their biological activities.

This article has been cited by other articles:

				M. Chang, K.-w. Peng, I. Kastrati, C. R. Overk, Z.-H. Qin, P. Yao, J. L. Bolton, and G. R. J. Thatcher Activation of Estrogen Receptor-Mediated Gene Transcription by the Equine Estrogen Metabolite, 4-Methoxyequilenin, in Human Breast Cancer Cells Endocrinology, October 1, 2007; 148(10): 4793 - 4802. [Abstract] [Full Text] [PDF]

				J. B. Becker, A. P. Arnold, K. J. Berkley, J. D. Blaustein, L. A. Eckel, E. Hampson, J. P. Herman, S. Marts, W. Sadee, M. Steiner, et al. Strategies and Methods for Research on Sex Differences in Brain and Behavior Endocrinology, April 1, 2005; 146(4): 1650 - 1673. [Abstract] [Full Text] [PDF]

				T. E. Sutherland, M. Schuliga, T. Harris, B. L. Eckhardt, R. L. Anderson, L. Quan, and A. G. Stewart 2-Methoxyestradiol Is an Estrogen Receptor Agonist That Supports Tumor Growth in Murine Xenograft Models of Breast Cancer Clin. Cancer Res., March 1, 2005; 11(5): 1722 - 1732. [Abstract] [Full Text] [PDF]

				R. T. Falk, T. R. Fears, X. Xu, R. N. Hoover, M. C. Pike, A. H. Wu, A. M.Y. Nomura, L. N. Kolonel, D. W. West, D. W. Sepkovic, et al. Urinary Estrogen Metabolites and Their Ratio among Asian American Women Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 221 - 226. [Abstract] [Full Text] [PDF]

				V K Turan, R I Sanchez, J J Li, S A Li, K R Reuhl, P E Thomas, A H Conney, M A Gallo, F C Kauffman, and S Mesia-Vela The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17{beta}-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16{alpha}-hydroxyestradiol, and 4-hydroxyestrone J. Endocrinol., October 1, 2004; 183(1): 91 - 99. [Abstract] [Full Text] [PDF]

				J. D. Sibonga, S. Lotinun, G. L. Evans, V. S. Pribluda, S. J. Green, and R. T. Turner Dose-Response Effects of 2-Methoxyestradiol on Estrogen Target Tissues in the Ovariectomized Rat Endocrinology, March 1, 2003; 144(3): 785 - 792. [Abstract] [Full Text] [PDF]

				T. M. LaVallee, X. H. Zhan, C. J. Herbstritt, E. C. Kough, S. J. Green, and V. S. Pribluda 2-Methoxyestradiol Inhibits Proliferation and Induces Apoptosis Independently of Estrogen Receptors {alpha} and {beta} Cancer Res., July 1, 2002; 62(13): 3691 - 3697. [Abstract] [Full Text] [PDF]

				A. M. Wilson and G. A. Reed Predominant 4-hydroxylation of estradiol by constitutive cytochrome P450s in the female ACI rat liver Carcinogenesis, February 1, 2001; 22(2): 257 - 263. [Abstract] [Full Text] [PDF]

				C. J. Haggans, E. J. Travelli, W. Thomas, M. C. Martini, and J. L. Slavin The Effect of Flaxseed and Wheat Bran Consumption on Urinary Estrogen Metabolites in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 719 - 725. [Abstract] [Full Text]

				T. Tsutsui, Y. Tamura, M. Hagiwara, T. Miyachi, H. Hikiba, C. Kubo, and J.C. Barrett Induction of mammalian cell transformation and genotoxicity by 2-methoxyestradiol, an endogenous metabolite of estrogen Carcinogenesis, April 1, 2000; 21(4): 735 - 740. [Abstract] [Full Text] [PDF]

				D. Liu and K. A. Bachmann An Investigation of the Relationship Between Estrogen, Estrogen Metabolites and Blood Cholesterol Levels in Ovariectomized Rats J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 561 - 568. [Abstract] [Full Text]